Search Results - "Perrone Filardi, P"

Refine Results
  1. 1

    The lipid theory in the pathogenesis of calcific aortic stenosis by Parisi, V, Leosco, D, Ferro, G, Bevilacqua, A, Pagano, G, de Lucia, C, Perrone Filardi, P, Caruso, A, Rengo, G, Ferrara, N

    “…Abstract Aims Biologically active phenomena, triggered by atherogenesis and inflammation, lead to aortic valve (AV) calcification. Lipids play an important…”
    Get full text
    Journal Article
  2. 2

    Vitamin D deficiency and clinical outcome in patients with chronic heart failure: A review by D'Amore, C., Marsico, F., Parente, A., Paolillo, S., De Martino, F., Gargiulo, P., Ferrazzano, F., De Roberto, A.M., La Mura, L., Marciano, C., Dellegrottaglie, S., Trimarco, B., Perrone Filardi, P.

    “…The aim of this review was to summarize evidence on the role of Vitamin D deficiency in heart failure (HF), from pathophysiological mechanisms to clinical…”
    Get full text
    Journal Article
  3. 3

    Blockade of β‐adrenoceptors restores the GRK2‐mediated adrenal α2‐adrenoceptor–catecholamine production axis in heart failure by Rengo, G, Lymperopoulos, A, Zincarelli, C, Femminella, GD, Liccardo, D, Pagano, G, de Lucia, C, Cannavo, A, Gargiulo, P, Ferrara, N, Perrone Filardi, P, Koch, WJ, Leosco, D

    Published in British journal of pharmacology (01-08-2012)
    “…BACKGROUND AND PURPOSE Sympathetic nervous system (SNS) hyperactivity is characteristic of chronic heart failure (HF) and significantly worsens prognosis. The…”
    Get full text
    Journal Article
  4. 4

    Changes in serum uric acid levels and cardiovascular events: A meta-analysis by Savarese, G, Ferri, C, Trimarco, B, Rosano, G, Dellegrottaglie, S, Losco, T, Casaretti, L, D'Amore, C, Gambardella, F, Prastaro, M, Rengo, G, Leosco, D, Perrone-Filardi, P

    “…Summary Background and Aims The association between serum uric acid (SUA) levels and cardiovascular (CV) risk or all-cause death has been repeatedly reported…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis by Gargiulo, P., Savarese, G., D'Amore, C., De Martino, F., Lund, L.H., Marsico, F., Dellegrottaglie, S., Marciano, C., Trimarco, B., Perrone-Filardi, P.

    “…Glucagon-like peptide-1 (GLP-1) agonists improve glycaemic control in type 2 diabetes mellitus (DM). Outcome trials investigating macro and microvascular…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Myocardial β2‐adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure by Rengo, G, Zincarelli, C, Femminella, GD, Liccardo, D, Pagano, G, de Lucia, C, Altobelli, GG, Cimini, V, Ruggiero, D, PerroneFilardi, P, Gao, E, Ferrara, N, Lymperopoulos, A, Koch, WJ, Leosco, D

    Published in British journal of pharmacology (01-08-2012)
    “…BACKGROUND AND PURPOSE We investigated whether β2‐adrenoceptor overexpression could promote angiogenesis and improve blood perfusion and left ventricular (LV)…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Implementation of cardiovascular secondary prevention guidelines in clinical practice: A nationwide survey in Italy by Perrone-Filardi, P, Poli, A, Ambrosio, G, Proto, C, Chimini, C, Chiariello, M

    “…Abstract Aims To report the implementation of cardiovascular secondary prevention guidelines following a cardiovascular event in Italy. Methods and results…”
    Get full text
    Journal Article
  14. 14

    Ultrasound and radiology surrogate endpoints in pharmacological studies by Agewall, S, deGroot, E, Marcos-Alberca, P, Zamorano, J.L, Barrero, A.A, Badano, L.P, Perrone-Filardi, P

    Published in Atherosclerosis (01-09-2012)
    “…Abstract Cardiovascular studies investigating therapeutic intervention with clinical endpoints are costly due to the need for considerable duration and large…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE by Savarese, G., Costanzo, P., Cleland, J.G.F., Vassallo, E., Ruggiero, D., Rosano, G., Perrone-Filardi, P.

    “…Translation articles: G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of…”
    Get full text
    Journal Article
  17. 17

    What is the relevance of the HOPE study in general practice? by Kennedy, J, Mogensen, C E, Ball, S G, Castaigne, A D, Commerford, P J, Distiller, L, Fisher, B M, Gonzalez-Jaunatey, J, Nosadini, R, Novials, A, Ostergren, J, Palma-Gámiz, J, Perrone-Filardi, P, Schipperheijn, J J, Senges, J, Trevisan, R

    “…The unique findings from the HOPE (Heart Outcomes Prevention Evaluation) study strongly support extending the use of the angiotensin-converting enzyme (ACE)…”
    Get more information
    Journal Article
  18. 18

    Use of Carotid Intima-Media Thickness Regression to Guide Therapy and Management of Cardiac Risks by Costanzo, P., Cleland, J. G., Atkin, S. L., Vassallo, E., Perrone-Filardi, P.

    “…Opinion statement Although carotid intima-media thickness (IMT) has been broadly used as a tool to evaluate cardiovascular risk, its role as a surrogate…”
    Get full text
    Journal Article
  19. 19

    Impaired left ventricular filling and regional diastolic asynchrony at rest in coronary artery disease and relation to exercise-induced myocardial ischemia by Perrone-Filardi, Pasquale, Bacharach, Stephen L., Dilsizian, Vasken, Bonow, Robert O.

    Published in The American journal of cardiology (15-02-1991)
    “…Impaired left ventricular (LV) diastolic filling at rest is frequently observed in patients with coronary artery disease (CAD) who have normal LV systolic…”
    Get full text
    Journal Article
  20. 20